Helen Davis

The new tool promises to transform customer service by providing real-time AI assistance, boosting agent performance in an increasingly complex support landscape.

Chinese giant Changan targets a top-5 MEA market rank by 2030, shifting from exports to deep local investment with its ambitious Vast Ocean Plan 2.0.

Plaud's new AI platform, Plaud Team, moves beyond note-taking to create a shared intelligence layer from meetings, calls, and in-person discussions.

A new report reveals that equipment fires, regulatory hurdles, and subtle operational flaws are emerging as major threats to the clean energy transition.

A 57-ton compressor's complex journey from Houston to Trinidad marks a pivotal moment for the nation's energy security and Touchstone's Cascadura project.

As Fabrinet preps for a key J.P. Morgan conference, record revenues clash with supply chain woes, putting its role in the AI revolution under a microscope.

Ottawa is set to announce a major sovereign data centre, part of a multi-billion dollar strategy to protect data and fuel a domestic AI boom.

Freshly rebranded Keel Infrastructure posts huge Q1 losses, but a $533M war chest and a 2.2GW pipeline show its real focus: the AI data center boom.

Actuate Therapeutics gets FDA nod for its oral cancer drug elraglusib, shifting strategy to improve patient outcomes and tackle hard-to-treat tumors.

As complex new global AI and data laws take effect, Canadian businesses are scrambling for guidance, fueling a boom in specialized advisory services.

With key clinical data on the horizon for its cancer and ALS drugs, LeonaBio adds deep financial, operational, and strategic expertise to its leadership.

ESR secures its fourth consecutive Red Dot Design Award, proving that innovative accessories are essential tools for today's flexible work and study life.

The food giant's Q1 results soar past expectations, validating its strategic pivot away from pork and focus on operational efficiency and brand power.

BiomX subsidiary Zorronet's new app brings AI security to the field, part of the parent company's radical pivot from biotech to defense technology.

Pet Honesty launches "The Honest Difference," a new standard for supplement transparency, and pledges a $1M product donation to pets in need.

RVL Pharmaceuticals claims double-digit growth for its eye drop Upneeq, but as a private firm, its disruptive direct-to-consumer model operates outside public view.

The architect of HUMIRA's launch and Horizon's $28B sale is now shaping the next wave of drug companies from within private equity. What does it mean?

Aptus Capital Advisors launches a new suite of deep buffered ETFs with a 0.25% fee, aiming to disrupt the market and offer a low-cost bond alternative.

As climate impacts escalate, investors are shifting focus from emissions to adaptation, funding startups that fortify our grid, water, and food systems.

While fighting a rare cancer, Maxim Harris created RagePADs, a viral hit for gamers. Now expanding globally, his company is built on purpose and charity.